Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Crushed Apixaban Tablets
NCT02101112Phase 1Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Mar 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of apixaban in thrombosis (3 arms), sponsored by Bristol Myers Squibb. Primary endpoints: Maximum Observed Plasma Concentration, Area Under the Plasma Concentration-time Curve From Time Zero Extrapolated to Infinite Time and 1 more. Started Mar 2014; status: completed.
02
Drugs
apixaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT02101112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02101112.